Investigating protein changes in aging and muscle function
Official title: Skeletal Muscle Myosin Binding Protein C in Fatigue and Aging
Run by University of Oregon · NCT05926219 · Data updated 2026-11-12
This study is trying to see how changes in muscle proteins affect strength and movement in older adults to help improve their recovery and mobility.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 80 Years |
| Sex | All |
| Enrollment | 24 (estimated) |
| Sponsor | University of Oregon Academic / other |
| Locations | 1 site (Eugene, Oregon) |
| Status | Recruiting |
| Started | November 6, 2017 |
| Main results expected | January 2027 |
| Study ends | January 2027 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT05926219 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18-35 or 65-80 who are willing to participate in all aspects of the study.
✕Probably not a fit
Patients with significant orthopedic limitations, untreated endocrine diseases, or severe chronic conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study examines how changes to proteins in skeletal muscle contribute to muscle atrophy and dysfunction associated with aging. It aims to understand the molecular mechanisms behind age-related muscle decline, which is crucial for enhancing rehabilitation strategies for older adults at risk of mobility impairment. The research involves pre-clinical evidence gathering through interventions like fatiguing exercise and muscle biopsies to identify specific protein modifications that may lead to improved physical function in frail older adults.
Why it matters
Potential benefit: If successful, this study could lead to new strategies for improving physical function and mobility in older adults suffering from muscle weakness and frailty.
How similar studies have gone: While the specific approach of this study may be novel, previous research has indicated that understanding protein changes in muscle can lead to advancements in treating age-related muscle decline.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults between the ages 18-35 or 65-80 years * Healthy by self-report * Willing to participate in all aspects of the study design including muscle biopsy, unilateral exercise, and physical activity monitoring * Fluent in English (due to lack of translation services, it is not practical to conduct the study using a language other than English). Exclusion Criteria: * Orthopaedic limitation (severe knee osteoarthritis, prior joint replacement, etc.). * Volunteer has dementia or related mental issues that potentially put the subject at risk as determined by prior diagnosis. * Volunteer has known untreated endocrine disease (hypo/hyper thyroidism, Addison's Disease or Cushing's syndrome, etc.) * Volunteer has untreated/poorly-controlled hypertension (stage 2, per American College of Cardiology \[\>140/90 mmHg\]). * Volunteer has significant heart, liver, kidney or respiratory disease. * Volunteer has diabetes (insulin dependent or non-insulin dependent). * Volunteer has known coagulopathies. * Volunteer has taken anabolic steroids in the prior six months. * Volunteer has received treatment for cancer (other than effective Mohs Surgery for successful removal of basal cell or squamous cell carcinomas) * Unexpected weight loss \>5kg is last 12 months * Volunteer is an active smoker or quit within the last year. * Volunteer has known current alcohol or drug use disorder (AUD; defined as binge drinking of \>4 days in the last month. Binge drinking is \>5 drinks for men and \>4 drinks for women, per occasion). Or, if a volunteer reports drinking in excess of "low risk" per NIAAA (\>7 drinks/week for men and \>3 drinks/day for women and \>14 drinks/week and \>4 drinks/day). * Volunteer has a diagnosed neuromuscular disorder. * Volunteer has allergy to lidocaine.
Where it's running
-
University of Oregon
Eugene, Oregon, United States Recruiting
Study contacts
- Principal investigator: Damien M Callahan, Ph.D. — University of Oregon
- Study coordinator: Damien M Callahan, Ph.D.
- Email: damienc@uoregon.edu
- Phone: 541-346-5040
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multicomponent prehabilitation for older adults with breast cancer
This program will test whether a multicomponent prehabilitation intervention (home-based or supervised) helps people aged 65 and older with breast cancer improve physical function, recovery after surgery, and quality of life while exploring biological markers that predict who benefits.
-
Effects of Rehabilitative Exergame Training on Foot Muscle Activity, Balance, and Mobility in Older Adults
In this study, healthy older adults will try an interactive game-based exercise program to see if it improves foot muscles, balance, and mobility compared with standard balance training.
-
Volunteer-led lifestyle program to help sarcopenia in older adults
This program tests a digital, volunteer-supported lifestyle plan to improve muscle health and reduce fall risk in older adults with sarcopenia or frailty.
-
SMILE: Tracking muscle loss, metabolic health, and aging over time
This project will follow adults to see if combining clinical data, imaging, and blood/tissue samples can detect and track muscle loss and metabolic changes linked to aging.
-
Randomized comparison of whole-body vibration plus usual care versus usual care to improve muscle health in older adults
This study will test whether adding a four-week, three-times-weekly whole-body vibration program to usual care helps pre-frail and mildly frail adults aged 65 and older improve muscle mass, strength, and function.
-
AMC6156 for older adults with sarcopenia
This trial will try once-daily AMC6156 pills or a placebo for 12 weeks to see if they improve strength and mobility in older adults with sarcopenia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.